Valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus: an economic perspective. [electronic resource]
Producer: 20170413Description: 334-41 p. digitalISSN:- 1399-3062
- Acyclovir -- administration & dosage
- Adult
- Antiviral Agents -- administration & dosage
- Cytomegalovirus -- drug effects
- Cytomegalovirus Infections -- economics
- Female
- Follow-Up Studies
- Ganciclovir -- administration & dosage
- Humans
- Kidney Transplantation -- adverse effects
- Male
- Middle Aged
- Postoperative Complications -- economics
- Valacyclovir
- Valganciclovir
- Valine -- administration & dosage
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.